Evidence map›Paper›PMID 39295846›Full record

ReviewFrontiers in bioengineering and biotechnology2024

Multiple applications of metal-organic frameworks (MOFs) in the treatment of orthopedic diseases.

Ziwen Zhao, Chenxu Wang, Aiguo Liu, Ning Bai, Bo Jiang, Yuanfu Mao, Ting Ying, Daming Dong, Chengqing Yi, Dejian Li

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ziwen Zhao *Department of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Chenxu Wang *Department of Orthopedics, The First Affiliated Hospital of Henan University, Kaifeng, China.
Aiguo Liu *Department of Orthopedics, The First Affiliated Hospital of Henan University, Kaifeng, China.
Ning BaiDepartment of Gastroenterology, Huaihe Hospital of Henan University, Kaifeng, China.
Bo JiangThe First Affiliated Hospital of Ningbo University, Ningbo, China.
Yuanfu MaoDepartment of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Ting YingShanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), School of Medicine, Tongji University, Shanghai, China.
Daming DongDepartment of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Chengqing YiDepartment of Orthopedics, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.
Dejian LiDepartment of Orthopedics, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacologic treatment of orthopedic diseases is a common challenge for clinical orthopedic surgeons, and as an important step in the stepwise treatment of orthopedic diseases, it is often difficult to achieve satisfactory results with existing pharmacologic treatments. Therefore, it is increasingly important to find new ways to effectively improve the treatment pattern of orthopedic diseases as well as to enhance the therapeutic efficacy. It has been found that metal-organic frameworks (MOFs) possess the advantages of high specific surface area, high porosity, chemical stability, tunability of structure and biocompatibility. Therefore, MOFs are expected to improve the conventional traditional treatment modality for bone diseases. This manuscript reviewed the applications of MOFs in the treatment of common clinical bone diseases and look forward to its future development.

Indexed as

metal-organic frameworksMOFsosteoarthritisosteoporosistumor

Identifiers

PMID39295846
PMCPMC11408336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.